Evidence map›Paper›PMID 32513098›Full record

ArticleBMC bioinformatics2020

PVAmpliconFinder: a workflow for the identification of human papillomaviruses from high-throughput amplicon sequencing.

Alexis Robitaille, Rosario N Brancaccio, Sankhadeep Dutta, Dana E Rollison, Marcis Leja, Nicole Fischer, Adam Grundhoff, Tarik Gheit, Massimo Tommasino, Magali Olivier

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 5 countries.

Alexis RobitailleInternational Agency for Research on Cancer, Lyon, France. alexis.robitaille@orange.fr.ORCID http://orcid.org/0000-0002-9749-8276
Rosario N BrancaccioInternational Agency for Research on Cancer, Lyon, France.
Sankhadeep DuttaInternational Agency for Research on Cancer, Lyon, France.
Dana E RollisonDepartment of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Marcis LejaInstitute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia.
Nicole FischerGerman Center for Infection Research, Hamburg-Borstel-Lübeck-Riems, Hamburg, Germany.
Adam GrundhoffGerman Center for Infection Research, Hamburg-Borstel-Lübeck-Riems, Hamburg, Germany.
Tarik GheitInternational Agency for Research on Cancer, Lyon, France.
Massimo TommasinoInternational Agency for Research on Cancer, Lyon, France. tommasinom@iarc.fr.
Magali OlivierInternational Agency for Research on Cancer, Lyon, France. olivierm@iarc.fr.
Centre international de recherche sur le cancer · FRChittaranjan National Cancer Institute · INLeibniz Institute of Virology (LIV) · DEMoffitt Cancer Center · USUniversität Hamburg · DEUniversity of Latvia · LV

Funding

NCI NIH HHS 1R01-CA17758World Health Organization 001
6 · The paper itself

Abstract

backgroundThe detection of known human papillomaviruses (PVs) from targeted wet-lab approaches has traditionally used PCR-based methods coupled with Sanger sequencing. With the introduction of next-generation sequencing (NGS), these approaches can be revisited to integrate the sequencing power of NGS. Although computational tools have been developed for metagenomic approaches to search for known or novel viruses in NGS data, no appropriate tool is available for the classification and identification of novel viral sequences from data produced by amplicon-based methods.

resultsWe have developed PVAmpliconFinder, a data analysis workflow designed to rapidly identify and classify known and potentially new Papillomaviridae sequences from NGS amplicon sequencing with degenerate PV primers. Here, we describe the features of PVAmpliconFinder and its implementation using biological data obtained from amplicon sequencing of human skin swab specimens and oral rinses from healthy individuals.

conclusionsPVAmpliconFinder identified putative new HPV sequences, including one that was validated by wet-lab experiments. PVAmpliconFinder can be easily modified and applied to other viral families. PVAmpliconFinder addresses a gap by providing a solution for the analysis of NGS amplicon sequencing, increasingly used in clinical research. The PVAmpliconFinder workflow, along with its source code, is freely available on the GitHub platform: https://github.com/IARCbioinfo/PVAmpliconFinder.

Indexed as

User-Computer InterfaceDNA, ViralHigh-Throughput Nucleotide SequencingHumansPapillomaviridaeWorkflowDNA, ViralAmplicon sequencingPapillomavirusPhylogenyVirus discoveryWorkflow

Identifiers

PMID32513098
PMCPMC7282039
OpenAlexW3033081459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.